Streetbeat News

Stock Prices

AAPL

FDX

LULU

NKE

QQQ

RDDT

SPY

TSLA

U.S. stocks are poised for a strong finish to the week, buoyed by rate-cut optimism and anticipation of Fed Chair Powell's speech. The S&P 500's rally this year is deemed 'perfectly normal' by analysts, following a downturn in the midterm year. Futures are up in premarket trading, with notable movements in individual stocks like FedEx, Lululemon, NIKE, and Tesla following earnings announcements and production news. Global markets show mixed reactions, with commodities and bonds also displaying varied trends.

Portfolio Pulse from Shanthi Rexaline

March 22, 2024 | 11:38 am

CDLX

ESOA

PHUN

TRDA

Insiders have made notable purchases in Cardlytics, Phunware, Energy Services of America, and Entrada Therapeutics, signaling confidence in these companies. Cardlytics' insider bought shares worth around $4.96 million, while Phunware's CFO, Energy Services of America's Director, and Entrada Therapeutics' Director also made significant purchases. These actions may indicate a bullish outlook for these stocks.

Portfolio Pulse from Avi Kapoor

March 22, 2024 | 11:29 am

TSLA

The resale market for Tesla Inc.'s Cybertruck is facing a downturn, with resale values plummeting from their peak. Prices have dropped significantly, with recent sales figures showing a decline from previous highs. Tesla's production ramp-up and a resale prohibition clause in their agreement, which restricts reselling within a year, are notable factors. Tesla aims to deliver 250,000 Cybertrucks annually by 2025, despite current market challenges.

Portfolio Pulse from Anan Ashraf

March 22, 2024 | 11:25 am

HYZN

Hyzon Motors reported FY23 sales of $0.295 million, a significant decrease from $3.726 million in the previous year. The company's earnings per share (EPS) also worsened, moving from $(0.13) to $(0.75) year-over-year. Hyzon Motors is set to report on Q4 2023.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 11:22 am

OKYO

OKYO Pharma's shares surged following the announcement that its OK-101 drug achieved statistical significance in treating multiple signs and symptoms of dry eye disease during its Phase 2 trial.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 11:12 am

RDDT

Reddit shares are trading lower following a surge during its NYSE debut on Thursday. The initial excitement around the stock's public offering has cooled off, leading to a decrease in its trading price.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 11:08 am

LI

Barclays analyst Jiong Shao has maintained an Overweight rating on Li Auto (NASDAQ:LI) but has lowered the price target from $56 to $39.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 11:07 am

BROS

Dutch Bros Inc. announced the pricing of a secondary public offering of 8 million Class A common shares at $34 per share, leading to a decrease in its stock price.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 11:07 am

AEVA

Aeva Technologies announced it has regained compliance with NYSE continued listing standards, indicating a positive development for the company's stock market presence.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 11:05 am

KBH

Barclays analyst Matthew Bouley has maintained an Overweight rating on KB Home (NYSE:KBH) and increased the price target from $75 to $77.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 11:04 am